Radboud University Medical Center
🇳🇱Netherlands
- Country
- 🇳🇱Netherlands
- Ownership
- Private
- Established
- 1951-01-01
- Employees
- -
- Market Cap
- -
- Website
- http://www.radboudumc.nl
Identification of Risk Factors for Acute Coronary Events by OCT After STEMI and NSTEMI in Patients With Residual Non-flow Limiting Lesions
Not Applicable
Active, not recruiting
- Conditions
- Myocardial InfarctionAcute Coronary SyndromeCoronary Artery Disease
- Interventions
- Device: Coronary Optical Coherence tomography
- First Posted Date
- 2019-02-28
- Last Posted Date
- 2021-09-17
- Lead Sponsor
- Radboud University Medical Center
- Target Recruit Count
- 438
- Registration Number
- NCT03857971
- Locations
- 🇳🇱
Radboudumc, Nijmegen, Zuid-Holland, Netherlands
Imaging Tumor-infiltrating T-cells in Non-small Cell Lung Cancer
Phase 2
Completed
- Conditions
- Non-small Cell Lung Cancer
- Interventions
- Radiation: Zr-89 labelled durvalumab PET/CT
- First Posted Date
- 2019-02-25
- Last Posted Date
- 2022-12-07
- Lead Sponsor
- Radboud University Medical Center
- Target Recruit Count
- 20
- Registration Number
- NCT03853187
- Locations
- 🇳🇱
Radboud University Medical Center, Nijmegen, Netherlands
Cost-effectiveness of Nursing Interventions for Patients With PD
Not Applicable
Completed
- Conditions
- Parkinson Disease
- Interventions
- Other: Parkinson's disease nurse specialist care
- First Posted Date
- 2019-02-05
- Last Posted Date
- 2023-11-22
- Lead Sponsor
- Radboud University Medical Center
- Target Recruit Count
- 242
- Registration Number
- NCT03830190
- Locations
- 🇳🇱
Radboud University Medical Center, Department of Neurology, Nijmegen, Gelderland, Netherlands
Lutetium-177-PSMA-617 in Low Volume Metastatic Prostate Cancer
- First Posted Date
- 2019-02-04
- Last Posted Date
- 2019-11-14
- Lead Sponsor
- Radboud University Medical Center
- Target Recruit Count
- 10
- Registration Number
- NCT03828838
- Locations
- 🇳🇱
Radiology and Nuclear Medicine, Nijmegen, Gelderland, Netherlands
PD-L1 ImagiNg to prediCt Durvalumab Treatment Response in HNSCC
Phase 1
Completed
- Conditions
- Head and Neck Cancer
- Interventions
- Diagnostic Test: PD-L1 imaging
- First Posted Date
- 2019-02-04
- Last Posted Date
- 2022-01-10
- Lead Sponsor
- Radboud University Medical Center
- Target Recruit Count
- 33
- Registration Number
- NCT03829007
- Locations
- 🇳🇱
UMC Groningen, Groningen, Netherlands
🇳🇱Amsterdam UMC, Amsterdam, Netherlands
🇳🇱Leiden UMC, Leiden, Netherlands
TreatmENT of AnastomotiC Leakage After Esophagectomy
Completed
- Conditions
- Esophageal CancerEsophageal Neoplasms
- First Posted Date
- 2019-02-04
- Last Posted Date
- 2022-04-01
- Lead Sponsor
- Radboud University Medical Center
- Target Recruit Count
- 1509
- Registration Number
- NCT03829098
- Locations
- 🇳🇱
Radboudumc surgical department, Nijmegen, Netherlands
Validation of USPIO-enhanced MRI for Detection of Lymph Node Metastases in Head and Neck Carcinoma
Not Applicable
Recruiting
- Conditions
- Head and Neck Squamous Cell Carcinoma
- Interventions
- Diagnostic Test: USPIO-enhanced MRI
- First Posted Date
- 2019-01-25
- Last Posted Date
- 2022-10-26
- Lead Sponsor
- Radboud University Medical Center
- Target Recruit Count
- 25
- Registration Number
- NCT03817307
- Locations
- 🇳🇱
Radboudumc, Nijmegen, Netherlands
Bioequivalence Study of Crushed Elbasvir/Grazoprevir Compared to the Whole Tablet
Phase 1
Completed
- Conditions
- Deglutition DisordersHepatitis C
- Interventions
- First Posted Date
- 2019-01-25
- Last Posted Date
- 2020-10-19
- Lead Sponsor
- Radboud University Medical Center
- Target Recruit Count
- 11
- Registration Number
- NCT03817619
- Locations
- 🇳🇱
RTCCS Radboudumc, Nijmegen, Netherlands
Discovery of Arthritis in Psoriasis Patients for Early Rheumatological Referral
Completed
- Conditions
- PsoriasisPsoriatic ArthritisPsoriasis VulgarisPsoriatic Nail
- Interventions
- Other: cutaneous parameters of psoriasis (exposure)Other: comorbidity (exposure)Other: family history (exposure)Other: lifestyle (exposure)Other: patient reported outcomes (exposure)Other: inflammatory markers (exposure)Other: genetic (exposure)
- First Posted Date
- 2019-01-25
- Last Posted Date
- 2022-07-29
- Lead Sponsor
- Radboud University Medical Center
- Target Recruit Count
- 304
- Registration Number
- NCT03816917
- Locations
- 🇳🇱
Radboudumc, Nijmegen, Netherlands
Safety and Efficacy of NF135 CPS Immunization
Not Applicable
Terminated
- Conditions
- Immunization; InfectionMalaria,FalciparumControlled Human Malaria Infection
- Interventions
- Biological: CPS-immunizationBiological: malaria challenge infection, P. falciparum NF54Biological: malaria challenge infection, P. falciparum NF135.C10Biological: CPS-immunization (A/L)
- First Posted Date
- 2019-01-23
- Last Posted Date
- 2023-05-26
- Lead Sponsor
- Radboud University Medical Center
- Target Recruit Count
- 43
- Registration Number
- NCT03813108
- Locations
- 🇳🇱
Radboud university medical centre, Nijmegen, Gelderland, Netherlands
© Copyright 2025. All Rights Reserved by MedPath